Suit filed against Uber and others after allegedly suffering a violent attack at the hands of a hailed driver in downtown ...

Sujal Patel, CEO of Nautilus Biotechnology Nautilus CEO Sujal Patel. (Nautilus Photo) Patel previously helped launch and lead Isilon Systems, which sold to EMC for $2.25 billion in 2010.

Biotech-startup CEOs are taking more nuanced approaches to going public amid a downturn. Insider talked to the leaders of five privately held biotechs for their views on IPOs in 2023.

N/A = not available. As you can see, some biotech CEOs made off like Wall Street tycoons in 2014, although how they got paid and whether they deserved their pay are both up for debate.

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.